Zunsemetinib
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
513.92
Molecular Formula
C25H22ClF2N5O3
Notes
Research use only, not for human use.
Receptor
MAPK
CAS Number
1640282-42-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1405834 Inquire
Recombinant Ashbya gossypii Putative transcription factor SEF1 (SEF1), partial
Ask
View Details 
